Pharmacogenomics is the practice of tailoring drugs to particular genetic profiles, with the
ambition of reducing instances of adverse reactions and ensuring optimal treatment.'1 0 …

The rediscovery of the clinical relevance of pharmacogenetics, which has since evolved into
pharmacogenomics, is the single most significant health care development in many years …

The opportunity for increased precision in pharmaceutical therapy will represent one of the
important legacies of the Human Genome Project. Medical researchers have long suspected …

Pharmacogenetics and pharmacogenomics explore why two patients who take the same
medicine may respond differently, reflecting individual differences in genes that affect …

Pharmacogenomics applies genomic technology to discover and develop drugs as well as
to treat patients more effectively. This article addresses legal questions raised by …

A patient comes to the hospital with a blood clot, and his physician presc blood thinner
Coumadin®(warfarin). The physician knows that people proce differently and that she must …

Although in 2001 both Sciencel and Nature2 published preliminary results of the human
genome project, pharmacogenomics 3 predates this milestone. In fact, some scientists …

Developments in pharmacogenetics make it possible to determine the genetic factors that
influence variations in response to medicine. Differences in response to medication may be …

In 2003, the completion of the Human Genome Project set the stage for new discoveries on
the role of genetics in disease and the development of new therapies tailored to the genetic …

The last decades have witnessed remarkable advancements in the fields of genetics and
genomics, highlighted by the successful completion of the map of the human genome in …